Parallel Advisors’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.4K | Sell |
1,594
-324
| -17% | -$5.77K | ﹤0.01% | 2014 |
|
|
2025
Q1 | $34.2K | Buy |
1,918
+100
| +6% | +$1.78K | ﹤0.01% | 1851 |
|
|
2024
Q4 | $54.2K | Buy |
1,818
+27
| +2% | +$805 | ﹤0.01% | 1580 |
|
|
2024
Q3 | $28K | Sell |
1,791
-72
| -4% | -$1.13K | ﹤0.01% | 1887 |
|
|
2024
Q2 | $31.9K | Buy |
1,863
+487
| +35% | +$8.34K | ﹤0.01% | 1732 |
|
|
2024
Q1 | $21.5K | Buy |
1,376
+1,109
| +415% | +$17.3K | ﹤0.01% | 1938 |
|
|
2023
Q4 | $3.99K | Buy |
267
+28
| +12% | +$418 | ﹤0.01% | 2586 |
|
|
2023
Q3 | $3.86K | Buy |
239
+223
| +1,394% | +$3.6K | ﹤0.01% | 2592 |
|
|
2023
Q2 | $664 | Sell |
16
-148
| -90% | -$6.14K | ﹤0.01% | 3037 |
|
|
2023
Q1 | $9.86K | Sell |
164
-346
| -68% | -$20.8K | ﹤0.01% | 2135 |
|
|
2022
Q4 | $37.4K | Buy |
510
+24
| +5% | +$1.76K | ﹤0.01% | 1410 |
|
|
2022
Q3 | $37K | Sell |
486
-66
| -12% | -$5.03K | ﹤0.01% | 1388 |
|
|
2022
Q2 | $38K | Sell |
552
-121
| -18% | -$8.33K | ﹤0.01% | 1380 |
|
|
2022
Q1 | $57K | Buy |
673
+226
| +51% | +$19.1K | ﹤0.01% | 1222 |
|
|
2021
Q4 | $34K | Buy |
447
+294
| +192% | +$22.4K | ﹤0.01% | 1529 |
|
|
2021
Q3 | $18K | Sell |
153
-6
| -4% | -$706 | ﹤0.01% | 1777 |
|
|
2021
Q2 | $35K | Buy |
159
+91
| +134% | +$20K | ﹤0.01% | 1397 |
|
|
2021
Q1 | $9K | Buy |
68
+16
| +31% | +$2.12K | ﹤0.01% | 1953 |
|
|
2020
Q4 | $9K | Buy |
+52
| New | +$9K | ﹤0.01% | 1815 |
|
|
2020
Q2 | – | Sell |
-3
| Closed | – | – | 2623 |
|
|
2020
Q1 | $0 | Buy |
+3
| New | – | ﹤0.01% | 2558 |
|